
BRICEF-S-1.5
Effective antibiotic for bacterial infections
BRICEF-S-1.5 is an injectable antibiotic combining ceftriaxone and sulbactam to treat a wide range of bacterial infections.
Bricef S 1.5 is a potent injectable antibiotic that combines ceftriaxone sodium and sulbactam sodium to effectively combat bacterial infections. This combination enhances the antibacterial activity by overcoming resistance mechanisms, making it a reliable choice for serious infections.
Manufactured under strict quality standards, Bricef S 1.5 is widely used in hospitals and clinics for its broad-spectrum activity and proven efficacy. It is particularly effective against resistant bacterial strains, ensuring faster recovery and improved patient outcomes.
Key Benefits:
- Broad-spectrum antibiotic coverage
- Effective against resistant bacteria due to sulbactam
- Rapid onset of action for critical infections
- Reduces risk of infection in surgical procedures
- Well-tolerated with a trusted safety profile
Active Ingredients:
Ingredient | Amount per Vial | Function |
---|---|---|
Ceftriaxone Sodium (eq. to Ceftriaxone) | 1000 mg | Broad-spectrum cephalosporin antibiotic |
Sulbactam Sodium (eq. to Sulbactam) | 500 mg | Beta-lactamase inhibitor to enhance antibiotic efficacy |
Free from gluten, lactose, and artificial preservatives. Consult a healthcare provider if allergic to cephalosporins or penicillins.
Recommended Uses:
Bricef S 1.5 is indicated for the treatment of various bacterial infections caused by susceptible organisms, including:
- Bacterial meningitis
- Lower respiratory tract infections
- Urinary tract infections
- Skin and soft tissue infections
- Septicemia
- Bone and joint infections
- Pre-operative prophylaxis to prevent surgical infections
Use only under medical supervision. Ensure bacterial susceptibility before initiating treatment.
Recommended Dosage:
Administration:
- Administer via intravenous (IV) or intramuscular (IM) injection
- Reconstitute with sterile water for injection or compatible diluent as per instructions
- Administer IV over 30 minutes; IM injections should be deep into large muscle mass
Dosage adjustments may be required in patients with renal or hepatic impairment. Consult a healthcare provider.
Common Side Effects:
- Pain or redness at injection site
- Diarrhea or nausea
- Rash or itching
Serious Side Effects (Seek Medical Attention Immediately):
- Severe allergic reactions (anaphylaxis, swelling, difficulty breathing)
- Severe diarrhea (possible Clostridium difficile infection)
- Jaundice or signs of liver dysfunction
- Blood disorders (e.g., leukopenia, thrombocytopenia)
Contraindications:
Do NOT use Bricef S 1.5 if you:
- Have a known allergy to ceftriaxone, sulbactam, or other cephalosporins
- Have a history of severe allergic reactions to penicillins
- Are a neonate with jaundice or receiving calcium-containing IV solutions
- Have severe renal and hepatic impairment combined
Storage Conditions:
- Store below 30°C in a dry place
- Protect from light and moisture
- Keep out of reach of children
- Store in original packaging until reconstitution
Shelf Life:
Bricef S 1.5 has a shelf life of 24 months from the date of manufacture when stored as recommended. Do not use after the expiration date.
Dispose of reconstituted solutions within 24 hours if stored at room temperature or 72 hours if refrigerated. Follow local guidelines for disposal.
Information provided is for educational purposes only. Always consult your healthcare provider before starting any medication. This product is available by prescription only in many countries. Follow your local regulations for proper acquisition and use of this medication.